Application of Ultrasound Artificial Intelligence and Elastography in Differential Diagnosis of Breast Nodules

NCT ID: NCT03887598

Last Updated: 2019-03-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-18

Study Completion Date

2020-02-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The application of computer-aided diagnosis (CAD) technology "S-Detect" enables qualitative and quantitative automated analysis of ultrasound images to obtain objective, repeatable and more accurate diagnostic results. The Elastic Contrast Index (ECI) technique, unlike conventional strain-elastic imaging techniques, can evaluate the elastic distribution in the region of interest. The purpose of the study was to evaluate the differential diagnosis value of ultrasound S-Detect technology for benign and malignant breast nodules and evaluate the differential diagnosis consistency of the ultrasound S-Detect technique and the examiner for benign and malignant breast nodules and explore the differential diagnosis value of Samsung ultrasound elastic contrast Index (ECI) technique for benign and malignant breast nodules.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Breast cancer is the most common malignancy in women and the second leading cause of cancer deaths worldwide. Therefore, early detection of breast cancer and timely treatment are of great significance for controlling and reducing breast cancer mortality. Breast ultrasound is an adjunct to extensive use in the detection of breast cancer, but ultrasound is highly technically dependent on the examiner, and the results are greatly influenced by the subjective nature of the examiner, adding unnecessary surgery and puncture, which causes great problems for clinicians and patients.Moreover, the value of conventional ultrasound in the differential diagnosis of breast mass is still limited, and the emergence of new technologies such as artificial intelligence and elastography has improved the accuracy of ultrasound diagnosis to varying degrees.

S-Detect technology is a computer-aided (CAD) system recently developed by Samsung Medical Center for breast ultrasound to assist in morphological analysis based on the Breast Imaging Reporting and Data System (BI-RADS) description and final assessment.This provides a new way to identify the benign and malignant breast nodules.

The E-Breast technique, unlike conventional strain-elastic imaging technology, performs an elastic analysis of the entire two-dimensional image.Moreover, when measuring the elastic ratio, it is only necessary to place a region of interest (ROI) at the nodule.Compared with the average elasticity of the surrounding area, it is more reflective of the elastic ratio of the mass to the surrounding tissue.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

breast nodule

Those with one or more breast nodules, age 18 or older, upcoming FNAB or surgery and signed informed consent.Those without adverse effects on the test or threatening other candidates, such as mental illness, pregnancy, poor ultrasound image quality, history of breast surgery or breast biopsy, simple cystic nodules, calcification, excessive mass or too small, the S-DetectTM system can not identify the boundary of the tumor, the basic information is incomplete.

Ultrasound diagnosis

Intervention Type DEVICE

Ultrasound diagnosis of lesions with Samsung S-Detect and ECI technology

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound diagnosis

Ultrasound diagnosis of lesions with Samsung S-Detect and ECI technology

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Had breast lesions detected by ultrasound
2. Age 18 or older
3. Upcoming FNAB or surgery
4. Signing informed consent

Exclusion Criteria

1. Patients who had received a biopsy of breast lesion before the ultrasound examination
2. Can not cooperate with the test operation
3. Patients who were pregnant or lactating
4. Patients who were undergoing neoadjuvant treatment.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

Sponsor Role collaborator

Taizhou Hospital

OTHER

Sponsor Role collaborator

Wuhan Hospital of Traditional Chinese Medicine

OTHER

Sponsor Role collaborator

Macheng People's Hospital

UNKNOWN

Sponsor Role collaborator

Huangshi Central Hospital

OTHER

Sponsor Role collaborator

Affiliated Hospital of Jiangsu University

OTHER

Sponsor Role collaborator

The First People's Hospital of Yichang

UNKNOWN

Sponsor Role collaborator

Yichang Second People's Hospital

OTHER

Sponsor Role collaborator

Xiangyang Central Hospital

OTHER

Sponsor Role collaborator

The Second Hospital of Anhui Medical University

OTHER

Sponsor Role collaborator

Anqing People's Hospital

UNKNOWN

Sponsor Role collaborator

Huainan People's Hospital

UNKNOWN

Sponsor Role collaborator

Wenzhou Central Hospital

OTHER

Sponsor Role collaborator

Xuzhou First People's Hospital

UNKNOWN

Sponsor Role collaborator

The Central Hospital of Lishui City

OTHER

Sponsor Role collaborator

Huai'an First People's Hospital

OTHER

Sponsor Role collaborator

WISCO General Hospital

UNKNOWN

Sponsor Role collaborator

First People's Hospital of Jiangxia District, Wuhan City

UNKNOWN

Sponsor Role collaborator

Enshi State Central Hospital

UNKNOWN

Sponsor Role collaborator

Lianyungang Third People's Hospital

UNKNOWN

Sponsor Role collaborator

First People's Hospital of Xianyang

OTHER

Sponsor Role collaborator

Xin-Wu Cui

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xin-Wu Cui

Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xin-Wu Cui, PhD,MD

Role: STUDY_CHAIR

Tongji Hospital

You-Bin Deng, PhD,MD

Role: STUDY_CHAIR

Tongji Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Xin-Wu Cui

Wuhan, Hubei, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Li-Qiang Zhou, MD

Role: CONTACT

15387076275

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xin-Wu Cui, PhD,MD

Role: primary

15927103161

You-Bin Deng, PhD,MD

Role: backup

13871197838

References

Explore related publications, articles, or registry entries linked to this study.

Choi JH, Kang BJ, Baek JE, Lee HS, Kim SH. Application of computer-aided diagnosis in breast ultrasound interpretation: improvements in diagnostic performance according to reader experience. Ultrasonography. 2018 Jul;37(3):217-225. doi: 10.14366/usg.17046. Epub 2017 Aug 14.

Reference Type RESULT
PMID: 28992680 (View on PubMed)

Kowal M, Filipczuk P, Obuchowicz A, Korbicz J, Monczak R. Computer-aided diagnosis of breast cancer based on fine needle biopsy microscopic images. Comput Biol Med. 2013 Oct;43(10):1563-72. doi: 10.1016/j.compbiomed.2013.08.003. Epub 2013 Aug 19.

Reference Type RESULT
PMID: 24034748 (View on PubMed)

Di Segni M, de Soccio V, Cantisani V, Bonito G, Rubini A, Di Segni G, Lamorte S, Magri V, De Vito C, Migliara G, Bartolotta TV, Metere A, Giacomelli L, de Felice C, D'Ambrosio F. Automated classification of focal breast lesions according to S-detect: validation and role as a clinical and teaching tool. J Ultrasound. 2018 Jun;21(2):105-118. doi: 10.1007/s40477-018-0297-2. Epub 2018 Apr 21.

Reference Type RESULT
PMID: 29681007 (View on PubMed)

Kim K, Song MK, Kim EK, Yoon JH. Clinical application of S-Detect to breast masses on ultrasonography: a study evaluating the diagnostic performance and agreement with a dedicated breast radiologist. Ultrasonography. 2017 Jan;36(1):3-9. doi: 10.14366/usg.16012. Epub 2016 Apr 14.

Reference Type RESULT
PMID: 27184656 (View on PubMed)

Wei Q, Yan YJ, Wu GG, Ye XR, Jiang F, Liu J, Wang G, Wang Y, Song J, Pan ZP, Hu JH, Jin CY, Wang X, Dietrich CF, Cui XW. The diagnostic performance of ultrasound computer-aided diagnosis system for distinguishing breast masses: a prospective multicenter study. Eur Radiol. 2022 Jun;32(6):4046-4055. doi: 10.1007/s00330-021-08452-1. Epub 2022 Jan 23.

Reference Type DERIVED
PMID: 35066633 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019(S073)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.